Lakeshore Biopharma (LSB) News Today $3.70 +0.09 (+2.49%) As of 01/3/2025 05:39 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period LakeShore Biopharma’s Financial Leap and Rabies Vaccine Trial ApprovalDecember 19, 2024 | markets.businessinsider.comLakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year GuidanceDecember 19, 2024 | prnewswire.comLakeShore Biopharma Co., Ltd: LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in ChinaDecember 13, 2024 | finanznachrichten.deLakeShore Biopharma Faces Challenges Amid Criminal Probe into Former ChairmanDecember 12, 2024 | markets.businessinsider.comLakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in ChinaDecember 12, 2024 | globenewswire.comLakeShore Biopharma Co Ltd Ordinary SharesNovember 23, 2024 | morningstar.comLakeShore Biopharma Advances PIKA Rabies Vaccine ApprovalNovember 8, 2024 | markets.businessinsider.comLakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of PakistanNovember 8, 2024 | markets.businessinsider.comLakeShore Biopharma Announces Leadership TransitionNovember 2, 2024 | markets.businessinsider.comLakeShore Biopharma Achieves Nasdaq Compliance MilestoneOctober 29, 2024 | markets.businessinsider.comLakeShore Biopharma regains ompliance with Nasdaq minimum bid price requirementOctober 29, 2024 | markets.businessinsider.comLakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price RequirementOctober 29, 2024 | prnewswire.comLakeShore Biopharma Advances with Rabies Vaccine TrialOctober 26, 2024 | markets.businessinsider.comLakeShore’s YSJA rabies vaccine receives approval for Phase III trial in ChinaOctober 26, 2024 | markets.businessinsider.comLakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies VaccineOctober 25, 2024 | prnewswire.comLakeShore Biopharma Shares Higher on Unchanged FY GuidanceOctober 10, 2024 | marketwatch.comLakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial GuidanceOctober 8, 2024 | prnewswire.comLakeShore Biopharma Co., Ltd (H6Z.F)October 2, 2024 | au.finance.yahoo.comLakeShore Biopharma Announces Results of Extraordinary General Meeting on Share ConsolidationSeptember 27, 2024 | prnewswire.comLakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024September 10, 2024 | prnewswire.comLakeShore Biopharma Announces Leadership TransitionsSeptember 4, 2024 | prnewswire.comLakeShore Biopharma Co., Ltd (LSB)September 3, 2024 | ca.finance.yahoo.comLakeShore Biopharma Co., Ltd (LSBPW)August 21, 2024 | uk.finance.yahoo.comLakeShore Biopharma Co., Ltd: LakeShore Biopharma Announces Financial Results for Fiscal Year 2024August 15, 2024 | finanznachrichten.deLakeShore Biopharma Co Ltd (LSB)August 15, 2024 | investing.comLakeShore Biopharma Announces Financial Results for Fiscal Year 2024August 15, 2024 | prnewswire.comLakeShore Biopharma Co. Ltd. WtAugust 15, 2024 | wsj.com Get Lakeshore Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LSB and its competitors with MarketBeat's FREE daily newsletter. Email Address LSB Media Mentions By Week LSB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LSB News Sentiment▼0.000.87▲Average Medical News Sentiment LSB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LSB Articles This Week▼01▲LSB Articles Average Week Get Lakeshore Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LSB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cassava Sciences News Today Tenaya Therapeutics News Today Alto Neuroscience News Today Leap Therapeutics News Today Cabaletta Bio News Today Protara Therapeutics News Today Acumen Pharmaceuticals News Today Cardiol Therapeutics News Today MediciNova News Today INmune Bio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LSB) was last updated on 1/5/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredNvidia second company to cross $3.5 trillion. It’s just the startNvidia has moved on to the next frontier of AI it intends to dominate. And we believe the three companies p...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lakeshore Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lakeshore Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.